Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (Q739328): Difference between revisions
From MaRDI portal
Removed claim: author (P16): Item:Q272701 |
Changed an Item |
||
| Property / author | |||
| Property / author: Piet H. van der Graaf / rank | |||
Normal rank | |||
Revision as of 11:34, 12 February 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis |
scientific article |
Statements
Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (English)
0 references
18 August 2016
0 references
PKPD modeling
0 references
HCV
0 references
mixture modeling
0 references
